UBS maintains a 'Buy' rating on Boston Scientific (NYSE: BSX), lowers price target from $9 to $8.

UBS analyst sees ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE